wbi@bwh.harvard.edu

DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression [RNA-seq]

GSE304087No linked publication

Hertie-Institute protocadherin silencing cohort

231 meningiomas profiled by DNA methylation array in this discovery cohort, cross-linked to a 10-sample bulk RNA-seq companion, both from the Hertie-Institute for Clinical Brain Research (corresponding authors Daniel J Merk and Ghazaleh Tabatabai). The study title, "DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression," points to protocadherin silencing as the central finding. A related 42-sample longitudinal methylation cohort from the same study (GSE304096) is recorded separately and is not itself flagged as multi-modal matched in this registry, though it shares the same investigators and study family. None of the three records has a linked publication yet, and none of them carry the peer_reviewed tag; treat findings as provisional until a paper is identified.

Modality
Bulk RNA-seq
Sample count
10
Patient count
Not reported
Institution
Hertie-Institute for Clinical Brain Research
Corresponding author
Daniel J Merk, Ghazaleh Tabatabai
Platform
Illumina NovaSeq 6000 (GPL24676)
Access type
open
Tissue preservation
Not reported
WHO edition
Not reported
Grade breakdown
Not reported
Sex distribution
Not reported
Age distribution
Not reported
Anatomic location
Not reported
Brain invasion
Not reported
Normal/control tissue
None
Linked to other modalitiesMolecular subtype annotated

No publication linked.

Also related: GSE304093, GSE304096, GSE304097

Sources

  • GEO
    https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304087